Applicable Procedure Codes: C9304, C9399, J3490, J3590, J7170, J7173, J7174, J7175, J7177, J7178, J7179, J7180, J7181, J7182, J7183, J7185, J7186, J7187, J7188, J7189, J7190, J7192, J7193, J7194, J7195, J7198, J7199, J7200, J7201, J7202, J7203, J7204, J7205, J7207, J7208, J7209, J7210, J7211, J7212, J7213, J7214
Einzelnachweise [Bearbeiten | Quelltext bearbeiten] INN Recommended List 63
Both treatments are administered once weekly by subcutaneous injection and are typically used alongside diet, exercise, and other diabetes medications such as metformin
The underlying amino acid sequence and mechanism remain the same regardless of vendor naming conventions
Visual cues or basic alerts are often more than enough to improve adherence
In a Phase 2 clinical trial published in 2023 in the New England Journal of Medicine (Jastreboff et al.), participants receiving the highest dose of retatrutide lost up to approximately 24% of their body weight over 48 weeks a notably greater reduction than observed with currently approved agents